Okay, hear’s a breakdown of the key information from the provided text, focusing on the study’s findings and implications.I’ll organize it for clarity:
Main Finding:
* GLP-1 receptor agonists (GLP-1 RAs) were associated with a 26% lower risk of colorectal cancer (CRC) compared to aspirin when used for
Worth a look